As reported in In the journal Cancer Cell, scientists at Albert Einstein College of Medicine in the Bronx, NY, explain how they tested the molecule, called BAX Trigger Site Activator 1 (BTSA1), on acute myeloid leukemia (AML) cells. They have developed a molecule that triggers cancer cells to die off without harming healthy cells.




Learn more here.